Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alcon Inc. Ordinary Shares (NY:ALC)

91.08 -1.52 (-1.64%)
Streaming Delayed Price Updated: 1:08 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alcon Inc. Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >
Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year
The biotech run off a June bottom is great — until you realize you could've netted more. 
Via Investor's Business Daily
Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Macy's, Palo Alto Networks And Other Big Gainers From Tuesday
U.S. stocks closed mostly lower with the Dow Jones dropping more than 150 points on Tuesday. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
Alcon May Struggle To Meet 2023 Margin Targets With This Latest Acquisition, Says This Analyst
Via Benzinga
Stocks Cut Lower As Dow Sheds Another Triple Digits
Though most sectors are suffering today, especially real estate and healthcare, energy stocks are on the rise as oil prices make a big resurgence. 
Via Talk Markets
Aerie Pharmaceuticals (NASDAQ: AERI) Enters into Agreement to be Acquired by Alcon (NYSE: ALC) for $770 Million
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) is engaged within the research, development and commercialization of ophthalmic therapies for the treatment of 
Via Spotlight Growth
Why Windtree Therapeutics Is Trading Higher By Over 60%, Here Are 61 Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Why Is Aerie Pharmaceuticals (AERI) Stock Up 35% Today?
Aerie Pharmaceuticals (AERI) stock is rising higher on Tuesday following news of a $770 million acquisition deal with Alcon (ALC). 
Via InvestorPlace
Blistering-Hot Biotech Shopping Spree Continues: Alcon To Buy Aerie For $770 Million
The biopharma buying spree continued Tuesday with glaucoma drugs maker Aerie. 
Via Investor's Business Daily
Why Zoom Video Is Trading Lower By 11%; Here Are 28 Stocks Moving Premarket
Gainers Quotient Limited (NASDAQ: QTNT) shares rose 58.2% to $0.3070 in pre-market trading. Quotient recently reported a wider Q1 loss. 
Via Benzinga
Palo Alto Networks, Aerie Pharmaceuticals And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
Alcon Buys Aerie Pharma For $770M To Enhance Its Ophthalmic Pharma Portfolio
Via Benzinga
U.S. Stock Futures Edge Higher Following Monday's Sell-Off, Crude Oil Rises
Pre-open movers 
Via Benzinga
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
From Alcon Inc. Investors
Via Business Wire
Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday's Mid-Day Session
Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 39.5% to $2.0380. 
Via Benzinga
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. 
Via Benzinga
WeTrade, Roblox And Some Other Big Stocks Moving Lower On Wednesday
  OptimizeRx Corporation (NASDAQ: OPRX) shares fell 26.7% to $16.32 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates. 
Via Benzinga
Why Is CarLotz Higher By More Than 30%: Here Are 28 Stocks Moving Premarket
Gainers ObsEva SA (NASDAQ: OBSV) shares rose 33.8% to $0.4080 in pre-market trading. ObsEva recently announced a $31 million debt retirement and $11 million debt refinancing. 
Via Benzinga
Alcon: Q2 Earnings Insights
  Alcon (NYSE:ALC) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Alcon beat estimated earnings by 28.57%,... 
Via Benzinga
Alcon Reports Second Quarter 2022 Results
From Alcon Inc. Investors
Via Business Wire
Earnings Preview For Alcon
  Alcon (NYSE:ALC) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that Alcon will report an... 
Via Benzinga
Football Star Cooper Kupp Encourages Eye Allergy Sufferers to Find the Right Tool for the Job with Pataday
From Alcon Inc. Corporate
Via Business Wire
Retina Technologies Reports Working With Major Health Systems To Boost Access to Eye Testing
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. While established manufacturers of... 
Via Benzinga
Alcon Prices EUR 500.0 Million Senior Notes Offering
From Alcon Inc. Investors
Via Business Wire
This Biopharma Stock Surges After Offloading Its Ophthalmic Eye Drop Portfolio
Via Benzinga
Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio
From Alcon Inc. Investors
Via Business Wire
Alcon: Q1 Earnings Insights
Alcon (NYSE:ALC) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Alcon beat estimated earnings by 38.78%,... 
Via Benzinga
Alcon Reports First Quarter 2022 Results
From Alcon Inc. Investors
Via Business Wire
Alcon Announces Results of 2022 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
Alcon’s SMARTCataract Demonstrates Enhanced Efficiency and Time Savings for Cataract Surgeries
From Alcon Inc. Corporate
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.